Global Custom Market Research Reports Provider Company

phone

Altor BioScience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 24
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Altor BioScience Corp (Altor BioScience) is a biopharmaceutical company that develops immunotherapies for the treatment of cancer and viral infections. The companys pipeline products include ALT-801, ALT-836, and ALT-803. Its technologies are soluble t-cell antigen receptor, inhibitor of MHC-peptide activation of t-cells screening, IL-15 protein superagonist and scaffold technology and tissue factor antagonist technology. Altor BioScience offers reagents for research and design of anti-viral and anti-cancer vaccines. The company provides targeted immunotherapeutic agents for inflammatory, cancer treatment, viral infections and autoimmune diseases. Altor BioScience is headquartered in Miramar, Florida, the US.

Altor BioScience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altor BioScience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Altor BioScience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Altor BioScience Raises USD30 Million in Venture Financing 11
Altor BioScience Raises USD20 Million in Financing Round 12
Altor Bioscience Raises US$5.5 Million In Venture Financing 13
Altor Bioscience Raises Additional US$1 Million In Series D Financing 14
Partnerships 15
Oxis International Enters into Co-Development Agreement with Altor BioScience 15
Altor BioScience Enters into Co-Development Agreement with NantKwest 16
Altor BioScience Enters into Co-Development Agreement with National Cancer Institute 17
Licensing Agreements 18
Altor BioScience Enters into Licensing Agreement with Shenzhen Beike Biotech for ALT-803 18
Acquisition 20
NantCell Acquires Altor BioScience 20
Altor BioScience Corp - Key Competitors 21
Altor BioScience Corp - Key Employees 22
Altor BioScience Corp - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables

List of Tables
Altor BioScience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altor BioScience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altor BioScience Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Altor BioScience Corp, Medical Devices Deals, 2012 to YTD 2018 9
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Altor BioScience Raises USD30 Million in Venture Financing 11
Altor BioScience Raises USD20 Million in Financing Round 12
Altor Bioscience Raises US$5.5 Million In Venture Financing 13
Altor Bioscience Raises Additional US$1 Million In Series D Financing 14
Oxis International Enters into Co-Development Agreement with Altor BioScience 15
Altor BioScience Enters into Co-Development Agreement with NantKwest 16
Altor BioScience Enters into Co-Development Agreement with National Cancer Institute 17
Altor BioScience Enters into Licensing Agreement with Shenzhen Beike Biotech for ALT-803 18
NantCell Acquires Altor BioScience 20
Altor BioScience Corp, Key Competitors 21
Altor BioScience Corp, Key Employees 22

List Of Figures

List of Figures
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Altor BioScience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Altor BioScience Corp, Medical Devices Deals, 2012 to YTD 2018 9

Altor BioScience Corp (Altor BioScience) is a biopharmaceutical company that develops immunotherapies for the treatment of cancer and viral infections. The companys pipeline products include ALT-801, ALT-836, and ALT-803. Its

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports